Eleos Inc. is a privately held corporation whose platform therapeutic Aezea™ is designed to make cancer cells more vulnerable to standard cancer treatments while protecting normal cells from the toxic effects these treatments often cause.

Corporate Office
F.J. Daugherty, MD
CEO
One Valmont Plaza
Suite 301
Omaha, Nebraska 68154
Phone: 402.255.5775
Fax: 402.255.5778

Regulatory Affairs
Dayton Reardan, PhD
Vice President
3033 Campus Drive
Suite W125
Plymouth, Minnesota 55441
Phone: 763.519.8600
Fax: 763.519.8619

Clinical Operations
Harry N. Cook, RPh, MBA
Vice President
3033 Campus Drive
Suite W125
Plymouth, Minnesota 55441
Phone: 763.519.8600
Fax: 763.519.8619

EleosInc. Ltd: Europe
Dayton Reardan, PhD
21 Wilson Street
London, EC2M 2TD
United Kingdom

This web site contains forward-looking statements. Certain unforeseen events may cause the company's actual results to differ materially from the results indicated by such statements.